Postmenopausal Osteoporosis
📧 Sign up to get email alerts when something new happens for Postmenopausal Osteoporosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2017-05-16Clinical Trial Update: The Prevalence of Osteoporotic Vertebral Compression Fractures (OVCF) in Korean Post Menopausal Women
This completed clinical trial from GlaxoSmithKline studied how common vertebral compression fractures are among Korean postmenopausal women.
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: Mediterranean Diet for Post-menopausal Women: Effects on Bone Turnover [NA]
This is a completed clinical trial evaluating the effect of a Mediterranean diet on bone turnover in postmenopausal women with osteoporosis …
-
FDA approval · 2017-04-28FDA Approved: TYMLOS — Original Application (Radius Health, Inc.)
The FDA approved TYMLOS (abaloparatide) from Radius Health as the original NDA for the treatment of postmenopausal osteoporosis in women at …
-
FDA approval · 2017-04-28FDA Approved: TERIPARATIDE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for teriparatide submitted by Prasco Laboratories. This action pertains to a supplemental approv…
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Efficacy Of Clodronate 200 Mg/4 Ml I.M. Solution With 1% Lidocaine Every Other Week Vs Clodronate 100 Mg/3,3ml I.M. Solution With 1% Lidocaine Once-Week In A 1-Year Treatment Period Of Women With Postmenopausal Osteoporosis [Phase 3]
This Phase 3 trial compares two clodronate regimens with lidocaine in postmenopausal osteoporosis over one year to evaluate efficacy.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Effects of Physical Exercise to Prevent Osteoporosis in Postmenopausal Women [NA]
This clinical trial update notes the completion of a study evaluating whether physical exercise can prevent osteoporosis in postmenopausal w…
-
CLINICAL_TRIALS research · 2017-03-27Clinical Trial Update: CLCF1 Gene Associated With Postmenopausal Osteoporosis of Kidney Yin Deficiency Syndrome [NA]
Clinical trial update examining the association between the CLCF1 gene and postmenopausal osteoporosis, including references to Kidney Yin D…
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: A Trial Evaluating the Effects of Zoledronic Acid 5 mg Infusion on Bone Mineral Density (BMD) in Postmenopausal Osteoporosis (PMO) Patients Between the Ages of 50 and 65 Years [Phase 3]
A Phase 3 trial evaluating the effects of a 5 mg zoledronic acid infusion on bone mineral density in postmenopausal osteoporosis patients ag…
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: The Study of LTBP1 of Postmenopausal Women Osteoporosis Molecular Mechanism of Kidney Yang Deficiency Syndrome
This completed clinical trial (NCT01940380) investigates the role of LTBP1 in postmenopausal osteoporosis and Kidney Yang Deficiency Syndrom…
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: Efficacy and Safety of Odanacatib (MK-0822) in Participants With Involutional Osteoporosis (MK-0822-022) [Phase 2]
Phase 2 trial evaluating efficacy and safety of odanacatib (MK-0822) in involutional osteoporosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women [Phase 3]
Phase 3 trial evaluating abaloparatide (BA058) for prevention of fractures in postmenopausal osteoporosis has completed, with results posted…
-
FDA approval · 2017-02-10FDA Approved: ABIGALE LO — Original Application (Xiromed LLC)
FDA approved ABIGALE LO, a generic combination of estradiol and norethindrone acetate, under an Original Application by Xiromed LLC. It is a…
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: Moringa Oleifera on Bone Density [NA]
A completed clinical trial evaluating the effect of Moringa Oleifera on bone density in osteoporosis and related conditions.
-
CLINICAL_TRIALS trial_result · 2016-12-19Clinical Trial Update: Phase 2 Study of BA058 (Abaloparatide) Transdermal Delivery in Postmenopausal Women With Osteoporosis [Phase 2]
Phase 2 study evaluating transdermal abaloparatide (BA058) in postmenopausal osteoporosis has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption [Phase 4]
Phase 4 trial assessing the acute effect of combining teriparatide with either a bisphosphonate or denosumab on bone resorption in postmenop…
-
CLINICAL_TRIALS trial_result · 2016-11-10Clinical Trial Update: ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis. [Phase 4]
A Phase 4 study (ExBonAdAsia) evaluating monthly ibandronate (Bonviva) in postmenopausal osteoporosis has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Study of Post Menopausal Osteoporosis (PMO) Among Gynecology Outpatients in Pakistan
The study on postmenopausal osteoporosis among gynecology outpatients in Pakistan has completed, sponsored by Hoffmann-La Roche. The snippet…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis [Phase 4]
A Phase 4 clinical trial evaluated adherence to monthly ibandronate (Bonviva) in women with postmenopausal osteoporosis. The study status is…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia [Phase 4]
Phase 4 clinical trial update on ibandronate (Boniva) to evaluate patient satisfaction in women with postmenopausal osteoporosis or osteopen…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis [Phase 4]
A Phase 4 clinical trial evaluating ibandronate (Bonviva) for post-menopausal osteoporosis has completed its study.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or Osteopenia [Phase 4]
This update notes the completion of the PRIOR Phase 4 study evaluating ibandronate (Boniva) in postmenopausal women with osteoporosis or ost…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Ibandronate [Bonviva/Boniva] and Alendronate in Female Patients With Post-Menopausal Osteoporosis
A completed clinical trial evaluating ibandronate (Boniva) and alendronate in postmenopausal osteoporosis.
-
CLINICAL_TRIALS withdrawal · 2016-11-02Clinical Trial Update: A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.
This clinical trial update notes that the quarterly intravenous ibandronate (Bonviva) study in women with postmenopausal osteoporosis is no …
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: Phase III Clinical Trial of DP-R206 and Bonvia In Postmenopausal Women With Osteoporosis [Phase 3]
A Phase III study evaluating DP-R206 and Bonvia for postmenopausal osteoporosis has completed; the update notes the status as completed.
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Denosumab China Phase III Study [Phase 3]
Phase III results for denosumab in Chinese postmenopausal osteoporosis patients. The trial has completed and results were posted in 2016.